Answers are grounded in this paper and cite their sources.
Obesity-induced metabolic syndrome is characterized by chronic inflammation, hormonal imbalance, and altered neurotransmitter metabolism. Zinc plays a critical role in immune regulation and energy balance; however, the effects of isotopically modified chelate complexes in metabolic functions remain unexplored. This study investigated the therapeutic effects of isotopically enriched Zn 64 Aspartate in a rat model of diet-induced obesity, focusing on inflammation, adipokine secretion, and tryptophan metabolism across serum, brain, duodenum, the pancreas, and adipose tissues. Male Wistar rats were fed a high-fat diet to induce obesity and treated with Zn 64 Aspartate. Proinflammatory and anti-inflammatory cytokine levels, resistin, ghrelin, serotonin, tryptophan concentrations, and enzymatic activities of tryptophan hydroxylase (TPH), indoleamine 2,3-dioxygenase (IDO), and monoamine oxidase (MAO) were analyzed. Zn 64 Aspartate significantly reduced pro-inflammatory cytokines and resistin levels while normalizing ghrelin. It enhanced serotonin levels and modulated TPH, IDO, and MAO activities in a tissue-specific manner, favoring serotonergic over kynurenine pathway metabolism. A decrease in pancreatic fibrosis, glycogen content, and an increase in the number of insulin-positive β-cells were observed in obese rats treated with Zn 64 Aspartate, compared with the obese group. Conclusively, Zn 64 Aspartate shows promise as a metabolic modulator by attenuating inflammation and restoring neuroendocrine balance in obesity. Further studies are warranted to validate its therapeutic potential.
No takes yet. Share an insight, caveat, or question.
Temnik et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: